Novel drug may prove useful as a treatment for dementia
A research team from Sage Therapeutics (MA, USA) have completed a preliminary study utilizing a novel drug – SAGE-718 – to treat mild cognitive impairment and dementia associated with Alzheimer’s disease.
Their findings suggest that SAGE-718 is safe and might be associated with improvements in executive function, thinking and memory skills. SAGE-718 is a positive allosteric modulator of N-methyl-D-aspartate receptors.
